Drugs Information:
Guanfacine
Basic Information
|
||
ID | DDInter847 | |
Drug Type | small molecule | |
Molecular Formula | C9H9Cl2N3O | |
Molecular Weight | 246.093 | |
CAS Number | 29110-47-2 | |
Description | Guanfacine, or BS 100-141,[A189838,A189841] is a selective alpha-A2 adrenergic receptor agonist initially indicated for the treatment of hypertension[L11274] but is now indicated as an extended release tablet for the treatment of ADHD.[L11277] Guanfacine was first described in the literature in 1974.[A189841] Guanfacine was granted FDA approval on 27 October 1986.[L11274] | |
ATC Classification | C02AC02 | |
IUPAC Name | N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide | |
InChI | INJOMKTZOLKMBF-UHFFFAOYSA-N | |
Canonical SMILES | NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Guide to Pharmacology Wikipedia ChEMBL ZINC |
Interactions with
Guanfacine
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|